4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-25-000082
Chief Medical Officer sold 11,914 shares at an average $37.99 ($452,601)
- Chief Medical Officer acquired 11,914 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Gheuens Sarah · Chief Medical Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-07-09 | Exercise or conversion : show line 1 in the form 10b5-1 | +11,914 | $25.01 | $297,969 | 73,185 | D |
| 2025-07-09 | Sale : show line 2 in the form 10b5-1 | −11,067 | $37.93 | $419,771 | 62,118 | D |
| 2025-07-09 | Sale : show line 3 in the form 10b5-1 | −847 | $38.76 | $32,830 | 61,271 | D |
| Open-market sales · 11,914 sh · avg $37.99 · $452,601 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-07-09 | Exercise or conversion : show line 4 in the form 10b5-1 Stock options (right to buy) | −11,914 | 32,086 | D |
Loading xslF345X05/wk-form4_1752267546.xml…